首页> 外文OA文献 >A tyrosine kinase inhibitor, β-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity

【2h】

A tyrosine kinase inhibitor, β-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity

机译：酪氨酸激酶抑制剂β-羟基异戊基紫草苷通过降低dUTP核苷酸水解酶活性诱导人肺癌DMS114细胞凋亡

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Kajimoto, Sachiko; Horie, Masayo; Manabe, Hitoshi; Masuda, Yutaka; Shibayama-Imazu, Toshiko; Nakajo, Shigeo; Gong, XiangFeng; Obama, Takashi; Itabe, Hiroyuki; Nakaya, Kazuyasu;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. 端粒酶RNA组分的反义寡核苷酸对BEL-7404人肝癌细胞端粒酶活性的抑制和细胞凋亡的诱导 [J] . 张如刚, 王兴旺, 谢弘分子细胞生物学报（英文版） . 2001,第003期
2. A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity. [J] . Kajimoto S, Horie M, Manabe H, Biochimica et biophysica acta. Bioenergetics . 2008,第1期

机译：酪氨酸激酶抑制剂β-羟基异戊基紫草苷通过降低dUTP核苷酸水解酶活性诱导人肺癌DMS114细胞凋亡。
3. A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity [J] . Kajimoto S, Horie M, Manabe H, Biochimica et biophysica acta. Molecular basis of disease: BBA . 2008,第1期

机译：酪氨酸激酶抑制剂β-羟基异戊基紫草苷通过降低dUTP核苷酸水解酶活性诱导人肺癌DMS114细胞凋亡
4. Beta-hydroxyisovalerylshikonin and cisplatin act synergistically to inhibit growth and to induce apoptosis of human lung cancer DMS114 cells via a tyrosine kinase-dependent pathway. [J] . Xu Y, Kajimoto S, Nakajo S, Oncology: International Journal of Cancer Research and Treatment . 2004,第1期

机译：β-羟基异戊基紫草苷和顺铂协同作用，通过酪氨酸激酶依赖性途径抑制人肺癌DMS114细胞的生长并诱导其凋亡。
5. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
6. The multi-targeted receptor tyrosine kinase inhibitor, linifanib (ABT-869), induces apoptosis and inhibits proliferation of leukemia cells through phosphoinositide-3 kinase (PI3K)/AKT-dependent signaling pathways. [D] . Hernandez, Jenny Elizabeth. 2010

机译：多靶点受体酪氨酸激酶抑制剂利尼法尼（ABT-869）通过磷酸肌醇3激酶（PI3K）/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
7. Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells [O] . Ling Fu, Liang Guo, Yi Zheng, -1

机译：低剂量c-Met酪氨酸激酶抑制剂和索拉非尼对人非小细胞肺癌细胞的协同抗肿瘤活性
8. A tyrosine kinase inhibitor, β-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity [O] . Kajimoto Sachiko, Horie Masayo, Manabe Hitoshi, 2008

机译：酪氨酸激酶抑制剂β-羟基异戊基紫草苷通过降低dUTP核苷酸水解酶活性诱导人肺癌DMS114细胞凋亡

A tyrosine kinase inhibitor, β-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅